BackAzurRx BioPharma Overview

AzurRx BioPharma Total Liabilities

Latest total liabilities for AZRX: $18M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$18.27M
↓ 38.44% YoYΔ $-11.41M vs prior year quarter

Peer trimmed avg / median

Loading

AzurRx BioPharma Total Liabilities History

Loading

AzurRx BioPharma vs. peers: Total Liabilities Comparison

Loading

AzurRx BioPharma Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AzurRx BioPharma (AZRX) FAQ

As of the most recent data (June 2026), AZRX shows a total liabilities of $18M. That compares with $30M in the prior-year period — down 38.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AZRX's total liabilities is now $18M (was $30M) — a 38.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AzurRx BioPharma is outperforming or lagging.

Tracking AZRX's total liabilities over time shows whether AzurRx BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $18M That compares with $30M in the prior-year period — down 38.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has AzurRx BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $18M) with ownership activity and broader fundamentals.

AzurRx BioPharma's total liabilities is $18M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.